Trial Profile
Effect of clopidogrel given as triple therapy (TOAT) in combination with warfarin+aspirin versus warfarin+aspirin (DOAT) or warfarin only (OAT) in electrical cardioversion undergoing patients with atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2015
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Warfarin; Warfarin/aspirin
- Indications Thrombosis
- Focus Therapeutic Use
- 26 May 2015 New trial record